Entering text into the input field will update the search result below

Synthetic Biologics, Inc's (SYN) CEO Steve Shallcross on Q4 2020 Results - Earnings Call Transcript

Mar. 04, 2021 10:01 PM ETTheriva Biologics, Inc. (TOVX)
SA Transcripts profile picture
SA Transcripts

Synthetic Biologics, Inc. (SYN) Q4 2020 Earnings Conference Call March 4, 2021 4:30 PM ET

Company Participants

Vincent Perrone - Director, Corporate Communication

Steve Shallcross - Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary, Director

Mike Kaleko - Senior Vice President Research and Development

Vince Wacher - Head, Product and Corporate Development

Conference Call Participants

Jim Molloy - Alliance Global Partners

Michael Okunewitch - Maxim Group


Good afternoon, and welcome to the Synthetic Biologics' 2020 Year End Investor Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communication at Synthetic Biologics. Please go ahead.

Vincent Perrone

Thanks, Gary and good afternoon, everyone. Welcome to Synthetic Biologics 2020 year end investor conference call. Today, I'm joined remotely by Steven Shallcross, Chief Executive and Financial Officer; Dr. Michael Kaleko, Senior Vice President Research and Development; and Dr. Vince Wacher, Head of Product and Corporate Development.

Synthetic Biologics issued a press release this afternoon, which provided operational highlights and reported our financial results for the year ending December 31, 2020. The release can be found on the Investor Relations section of our website.

During our call today, we'll provide an operational update on our GI and microbiome-focused clinical programs and summarize our financial results. We'll take questions after prepared remarks. In addition to the phone line, this call will be streamed live via webcast and will be archived on our website www.syntheticbiologics.com for 90 days.

During this call, we will be making forward-looking statements regarding Synthetic Biologics' current expectations and projections about future events. Generally, the forward-looking statements can be identified by terminology such as may, should, expects, anticipates, intends, plans, believes, estimates

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.